Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-20-064127

President and CEO gave up 871 shares (to pay taxes)

  • President and CEO acquired 3,034 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Walker Neal President and CEO 2020-12-15 Option exercise +3,034 1,149,185 D: show line 1 in the form
Walker Neal President and CEO 2020-12-15 Shares withheld for taxes −871 $4.59 $3,998 1,148,314 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Walker Neal President and CEO 2020-12-15 Option exercise · Restricted Stock Units −3,034 0 D: show line 3 in the form
Loading xslF345X03/doc4.xml…